Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study release_5iltuzlewjfirbnsukgsruauaq

by Hyuktae Kwon, Donghee Kim, Joo Sung Kim

References

This release citing other releases
  1. World Health Organization. Global status report on noncommunicable diseases 2014. (Geneva, 2014).
  2. Nat Rev Immunol.2011.Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85–97 (2011). (DOI: 10.1038/nri2921)
  3. JAMA.2002.Lakka, H. M. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709–2716 (2002). (DOI: 10.1001/jama.288.21.2709)
  4. European Heart Journal.2007.Wang, J. et al. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. European Heart Journal 28, 857–864, doi: 10.1093/eurheartj/ehl524 (2007). (DOI: 10.1093/eurheartj/ehl524)
  5. Diabetes Metab J.2011.Oh, S. W. Obesity and Metabolic Syndrome in Korea. Diabetes Metab J 35, 561–566 (2011). (DOI: 10.4093/dmj.2011.35.6.561)
  6. Diabetes care.2011.Mozumdar, A. & Liguori, G. Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006. Diabetes care 34, 216–219, doi: 10.2337/dc10-0879 (2011). (DOI: 10.2337/dc10-0879)
  7. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and Interna.2009.Alberti, K. G. M. M. et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity 120, 1640–1645, doi: 10.1161/circulationaha.109.192644 (2009). (DOI: 10.1161/circulationaha.109.192644)
  8. Diabetes care.2010.Yim, J. Y. et al. Sagittal Abdominal Diameter Is a Strong Anthropometric Measure of Visceral Adipose Tissue in the Asian General Population. Diabetes care 33, 2665–2670, doi: 10.2337/dc10-0606 (2010). (DOI: 10.2337/dc10-0606)
  9. Obesity.2013.Neeland, I. J. et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity 21, E439–E447, doi: 10.1002/oby.20135 (2013). (DOI: 10.1002/oby.20135)
  10. J Atheroscler Thromb.2012.Oka, R. et al. Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb 19, 814–822 (2012). (DOI: 10.5551/jat.12294)
  11. J Clin Endocrinol Metab.2011.McLaughlin, T., Lamendola, C., Liu, A. & Abbasi, F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 96, E1756–1760, doi: 10.1210/jc.2011-0615 (2011). (DOI: 10.1210/jc.2011-0615)
  12. Circulation.2007.Fox, C. S. et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39–48, doi: 10.1161/CIRCULATIONAHA.106.675355 (2007). (DOI: 10.1161/circulationaha.106.675355)
  13. Diabetes care.2009.Porter, S. A. et al. Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes care 32, 1068–1075, doi: 10.2337/dc08-2280 (2009). (DOI: 10.2337/dc08-2280)
  14. J Clin Endocrinol Metab.2010.Liu, J. et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 95, 5419–5426, doi: 10.1210/jc.2010-1378 (2010). (DOI: 10.1210/jc.2010-1378)
  15. The American journal of clinical nutrition.2011.Wildman, R. P. et al. Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women. The American journal of clinical nutrition 93, 719–726, doi: 10.3945/ajcn.110.007153 (2011). (DOI: 10.3945/ajcn.110.007153)
  16. Proceedings of the Japan Academy, Series B.2012.Nakao, Y. M. et al. Intra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study). Proceedings of the Japan Academy, Series B 88, 454–461, doi: 10.2183/pjab.88.454 (2012). (DOI: 10.2183/pjab.88.454)
  17. Nature.2006.Despres, J.-P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881–887 (2006). (DOI: 10.1038/nature05488)
  18. Obesity Reviews.2010.Ibrahim, M. M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity Reviews 11, 11–18, doi: 10.1111/j.1467-789X.2009.00623.x (2010). (DOI: 10.1111/j.1467-789x.2009.00623.x)
  19. Diabetes care.2011.Kim, S. et al. Distribution of Abdominal Visceral and Subcutaneous Adipose Tissue and Metabolic Syndrome in a Korean Population. Diabetes care 34, 504–506, doi: 10.2337/dc10-1364 (2011). (DOI: 10.2337/dc10-1364)
  20. Obes Res Clin Pract.2010.Song, S. W. et al. Relationships between visceral adipose tissue measurement site and the metabolic syndrome in the Korean population. Obes Res Clin Pract 4, e247–342, doi: 10.1016/j.orcp.2010.06.002 (2010). (DOI: 10.1016/j.orcp.2010.06.002)
  21. Circulation.2015.Abraham, T. M., Pedley, A., Massaro, J. M., Hoffmann, U. & Fox, C. S. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation 132, 1639–1647, doi: 10.1161/circulationaha.114.015000 (2015). (DOI: 10.1161/circulationaha.114.015000)
  22. Journal of the American College of Cardiology.2016.Lee, J. J., Pedley, A., Hoffmann, U., Massaro, J. M. & Fox, C. S. Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors. Journal of the American College of Cardiology 68, 1509–1521, doi: 10.1016/j.jacc.2016.06.067 (2016). (DOI: 10.1016/j.jacc.2016.06.067)
  23. JACC Cardiovasc Imaging.2014.Shah, R. V. et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging 7, 1221–1235, doi: 10.1016/j.jcmg.2014.07.017 (2014). (DOI: 10.1016/j.jcmg.2014.07.017)
  24. PloS one.2011.Kang, S. M. et al. Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people. PloS one 6, e27694, doi: 10.1371/journal.pone.0027694 (2011). (DOI: 10.1371/journal.pone.0027694)
  25. Diabetes.2004.Carr, D. B. et al. Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome. Diabetes 53, 2087–2094, doi: 10.2337/diabetes.53.8.2087 (2004). (DOI: 10.2337/diabetes.53.8.2087)
  26. A Scientific Statement From the American Heart Association.2011.Cornier, M.-A. et al. Assessing Adiposity. A Scientific Statement From the American Heart Association 124, 1996–2019, doi: 10.1161/CIR.0b013e318233bc6a (2011). (DOI: 10.1161/cir.0b013e318233bc6a)
  27. Physiological Reviews.2013.Trayhurn, P. Hypoxia and Adipose Tissue Function and Dysfunction in Obesity. Physiological Reviews 93, 1–21, doi: 10.1152/physrev.00017.2012 (2013). (DOI: 10.1152/physrev.00017.2012)
  28. Journal of Nutrition and Metabolism.2012.Di Chiara, T., Argano, C., Corrao, S., Scaglione, R. & Licata, G. Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. Journal of Nutrition and Metabolism 2012, 175245, doi: 10.1155/2012/175245 (2012). (DOI: 10.1155/2012/175245)
  29. Obesity.2010.Samaras, K., Botelho, N. K., Chisholm, D. J. & Lord, R. V. Subcutaneous and Visceral Adipose Tissue Gene Expression of Serum Adipokines That Predict Type 2 Diabetes. Obesity 18, 884–889, doi: 10.1038/oby.2009.443 (2010). (DOI: 10.1038/oby.2009.443)
  30. Obesity Reviews.2000.Bosello, O. & Zamboni, M. Visceral obesity and metabolic syndrome. Obesity Reviews 1, 47–56, doi: 10.1046/j.1467-789x.2000.00008.x (2000). (DOI: 10.1046/j.1467-789x.2000.00008.x)
  31. Diabetes.2003.Virtanen, K. A. et al. Differential Effects of Rosiglitazone and Metformin on Adipose Tissue Distribution and Glucose Uptake in Type 2 Diabetic Subjects. Diabetes 52, 283–290, doi: 10.2337/diabetes.52.2.283 (2003). (DOI: 10.2337/diabetes.52.2.283)
  32. Diabetes care.2012.Golan, R. et al. Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes care 35, 640–647, doi: 10.2337/dc11-1583 (2012). (DOI: 10.2337/dc11-1583)
  33. Obesity research.2003.Deschênes, D., Couture, P., Dupont, P. & Tchernof, A. Subdivision of the Subcutaneous Adipose Tissue Compartment and Lipid-Lipoprotein Levels in Women. Obesity research 11, 469–476, doi: 10.1038/oby.2003.64 (2003). (DOI: 10.1038/oby.2003.64)
  34. Obesity.2008.Koska, J. et al. Distribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex-specific Manner. Obesity 16, 2003–2009, doi: 10.1038/oby.2008.292 (2008). (DOI: 10.1038/oby.2008.292)
  35. Clinical Gastroenterology and Hepatology.2016.Kim, D. et al. Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 14, 132–138.e134, doi: 10.1016/j.cgh.2015.07.024 (2016). (DOI: 10.1016/j.cgh.2015.07.024)
  36. Medicine.2015.Chung, G. E. et al. Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease. Medicine 94, e573, doi: 10.1097/md.0000000000000573 (2015). (DOI: 10.1097/md.0000000000000573)
  37. Liver International.2017.Kwak, M.-S., Kim, D., Chung, G. E., Kim, W. & Kim, J. S. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease. Liver International 37, 919–926, doi: 10.1111/liv.13332 (2017). (DOI: 10.1111/liv.13332)
  38. Liver International.2015.Kwak, M.-S. et al. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver International 35, 944–952, doi: 10.1111/liv.12552 (2015). (DOI: 10.1111/liv.12552)
  39. Gut.2008.Chung, S. J. et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 57, 1360–1365, doi: 10.1136/gut.2007.147090 (2008). (DOI: 10.1136/gut.2007.147090)
  40. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.2005.Grundy, S. M. et al. Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement 112, 2735–2752, doi: 10.1161/circulationaha.105.169404 (2005). (DOI: 10.1161/circulationaha.105.169404)
  41. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment (2000).